Silo Pharma, Inc. – NASDAQ:SILO
Silo Pharma stock price today
Silo Pharma stock price monthly change
Silo Pharma stock price quarterly change
Silo Pharma stock price yearly change
Silo Pharma key metrics
Market Cap | 3.73M |
Enterprise value | N/A |
P/E | -1.14 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 44.35 |
Price/Book | 0.46 |
PEG ratio | N/A |
EPS | -1.2 |
Revenue | 72.10K |
EBITDA | -3.70M |
Income | -3.59M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -4781.21% |
Oper. margin | -4298.73% |
Gross margin | 91.9% |
EBIT margin | -4298.73% |
EBITDA margin | -5139.75% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSilo Pharma stock price history
Silo Pharma stock forecast
Silo Pharma financial statements
| Jun 2023 | 18.02K | -1.01M | -5619.7% |
|---|---|---|---|
| Sep 2023 | 18.02K | -660.16K | -3662.47% |
| Dec 2023 | 18.02K | -1.12M | -6219.77% |
| Mar 2024 | 18.02K | -801.66K | -4447.28% |
| 2025 | 70K | -2.15M | -3079.87% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-11-13 | -0.2 | -0.21 |
|---|---|---|
| 2024-03-25 | -0.2 | -0.36 |
| Jun 2023 | 10245587 | 1.94M | 19.03% |
|---|---|---|---|
| Sep 2023 | 8987037 | 1.49M | 16.58% |
| Dec 2023 | 7746141 | 1.56M | 20.26% |
| Mar 2024 | 6941409 | 1.64M | 23.76% |
| Jun 2023 | -549.96K | -3.82M | -130.95K |
|---|---|---|---|
| Sep 2023 | -1.07M | 1.25M | -145.73K |
| Dec 2023 | -910.01K | 4.42M | -194.42K |
| Mar 2024 | -838.17K | 97.59K | -115.45K |
Silo Pharma alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Silo Pharma other data
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 3408 | 0 |
| Apr 2024 | 2100 | 0 |
| Jun 2024 | 5000 | 0 |
| Nov 2024 | 5000 | 0 |
| Dec 2024 | 2500 | 0 |
-
What's the price of Silo Pharma stock today?
One share of Silo Pharma stock can currently be purchased for approximately $0.64.
-
When is Silo Pharma's next earnings date?
Unfortunately, Silo Pharma's (SILO) next earnings date is currently unknown.
-
Does Silo Pharma pay dividends?
No, Silo Pharma does not pay dividends.
-
How much money does Silo Pharma make?
Silo Pharma has a market capitalization of 3.73M. Silo Pharma made a loss 3.7M US dollars in net income (profit) last year or -$0.36 on an earnings per share basis.
-
What is Silo Pharma's stock symbol?
Silo Pharma, Inc. is traded on the NASDAQ under the ticker symbol "SILO".
-
What is Silo Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Silo Pharma?
Shares of Silo Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Silo Pharma have?
As Jul 2024, Silo Pharma employs 3 workers.
-
When Silo Pharma went public?
Silo Pharma, Inc. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.
-
What is Silo Pharma's official website?
The official website for Silo Pharma is silopharma.com.
-
Where are Silo Pharma's headquarters?
Silo Pharma is headquartered at 677 N. Washington Boulevard, Sarasota, FL.
-
How can i contact Silo Pharma?
Silo Pharma's mailing address is 677 N. Washington Boulevard, Sarasota, FL and company can be reached via phone at +7 184009031.
Silo Pharma company profile:
Silo Pharma, Inc.
silopharma.comNASDAQ
3
Biotechnology
Healthcare
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Sarasota, FL 34236
CIK: 0001514183
ISIN: US82711P2011
CUSIP: 82711P102
